scispace - formally typeset
Search or ask a question
Institution

Rhône-Poulenc

About: Rhône-Poulenc is a based out in . It is known for research contribution in the topics: Alkyl & Catalysis. The organization has 8909 authors who have published 8934 publications receiving 182241 citations. The organization is also known as: Rhone-Poulenc.


Papers
More filters
Journal ArticleDOI
M. J. Parnham1, S. Leyck1, E. Graf1, E. J. Dowling2, D. R. Blake2 
TL;DR: Ebselen has been demonstrated to be an effective anti-inflammatory agent in a variety of experimental modelsin vivo which differ from classical tests in that the aetiological roles of hydroperoxide and/or lipoxygenase products appear to be greater.
Abstract: Ebselen has been demonstrated to be an effective anti-inflammatory agent in a variety of experimental modelsin vivo which differ from classical tests in that the aetiological roles of hydroperoxides and/or lipoxygenase products appear to be greater. Indeed, ebselen exhibits only weak anti-inflammatory activity in the traditional prostaglandin-dominated models, such as carrageenan paw oedema, adjuvant arthritis and yeast paw hyperalgesia [50]. The major targets of this anti-inflammatory activity appear to be plasma exudation and infiltration, possibly as a result of the inhibition of the hydroperoxide and/or leukotriene effects on leukocyte-endothelium interactions. Both reactive oxygen species [24] and LTB4 [51, 52] enhance granulocyte adhesiveness to endothelium and ebselen inhibits the generation of reactive oxygen species, catalyses the breakdown of hydroperoxides, inactivates LTB4 by isomerization and inhibits 5-lipoxygenase [9–11, 13–16, 27–29]. Consequently, any or all of these mechanisms of action, together with inhibition of hypoxic-reperfusion injury [53], could contribute to the anti-inflammatory activity of ebselen.

50 citations

Journal ArticleDOI
TL;DR: Results indicate that selective NK1 receptor antagonists could be potentially effective for the treatment of migraine headache.

50 citations

Journal ArticleDOI
TL;DR: The solution of sodium trifluoromethanesulfinate (sodium triflinate) and phosphoryl chloride (2 1 ), in AcOEt, behaves like an equivalent of the CF 3 S(O) + cation as mentioned in this paper.

50 citations

Patent
30 Aug 1994
TL;DR: In this paper, the process for the treatment of cellulose for activation for subsequent chemical reactions by bringing the cellulose in contact with liquid ammonia at a pressure higher than atmospheric pressure in a pressure vessel and subsequent expansion by rapid reduction of the pressure to atmospheric pressure, is carried out by using a cellulose pulp of an alpha-cellulose content of at least 92 mass %, letting the ammonia act on the pulp at room temperature or at a temperature higher than room temperature.
Abstract: The process for the treatment of cellulose for activation for subsequent chemical reactions by bringing the cellulose in contact with liquid ammonia at a pressure higher than atmospheric pressure in a pressure vessel and subsequent expansion by rapid reduction of the pressure to atmospheric pressure, is carried out by using a cellulose pulp of an alpha-cellulose content of at least 92 mass %, letting the ammonia act on the pulp at room temperature or at a temperature higher than room temperature, after the expansion, removing the ammonia then still remaining in the pressure vessel except for a minimum content at which the state of activation reached by the action of the ammonia is still maintained and finally replacing the residual ammonia still needed to maintain the state of activation by another swelling or inclusion agent. The process is suitable, also on a large industrial scale, especially for the activation of pulp subsequently to be acetylated and makes possible to achieve a homogenous and high-grade activation. Further, no costly cooling apparatus is needed.

50 citations

Journal ArticleDOI
TL;DR: A survey was performed on the results of 138 carcinogenicity studies conducted in various mouse strains by the agrochemical industry over the period 1983-1993, showing a clear relationship between hepatomegaly at 1 year after exposure and a positive tumorigenic outcome at 18 months or 2 years after exposure.
Abstract: A survey was performed on the results of 138 carcinogenicity studies conducted in various mouse strains by the agrochemical industry over the period 1983-1993. Data for liver tumor incidence, liver weight, and histopathology were collected along with data on genotoxicity. Studies were judged positive or negative for liver tumor formation on the basis of apparent dose response, malignancy, and difference from historical control values using a weight of evidence approach. Thirty-seven studies were judged to be positive for liver tumorigenicity in one or both sexes. There was no evidence showing an influence of the mouse strain and the duration of the study on the proportion of positive studies. Although 8 of the chemicals tested in the 138 studies were positive in the Ames test, only one of these was judged positive for carcinogenicity. Only 6 of the 37 positive chemicals had any other reported positive genotoxicity findings. A clear relationship between hepatomegaly at 1 year after exposure and a positive tumorigenic outcome at 18 months or 2 years after exposure was demonstrated. Whereas the average relative liver weight of top dose animals was 110% of control in negative studies, it was 150% in positive studies. Likewise, very few negative studies demonstrated significant pathological findings after 1 year, whereas the majority of positive studies had significant liver pathology. The implications of these findings for extrapolation to humans are discussed.

50 citations


Authors

Showing all 8909 results

NameH-indexPapersCitations
Bart Staels15282486638
Joseph Schlessinger15049298862
Jean-Marie Lehn123105484616
Angus C. Nairn11846944330
Allan I. Basbaum11435555532
Patrick Couvreur11167856735
Joël Vandekerckhove10745238241
Jules A. Hoffmann10624443596
Johan Richard9549925915
Jacques Mallet8140824502
Roland Douce8028418239
David Givol8026020057
Jean-Antoine Girault7724619592
Michel Perricaudet7629620063
Jean-Marie Basset7573723390
Network Information
Related Institutions (5)
Merck & Co.
48K papers, 1.9M citations

89% related

Bristol-Myers Squibb
21K papers, 932.5K citations

88% related

GlaxoSmithKline
21.1K papers, 1.1M citations

87% related

Novartis
50.5K papers, 1.9M citations

87% related

Eli Lilly and Company
22.8K papers, 946.7K citations

87% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20201
20161
20119
201024
20095
20081